Aurora cannabis announces fiscal 2023 first quarter results

Nasdaq | tsx: acb reiterates reaching adjusted ebitda profitability by december 31, 2022 reaffirms $150 to $170 million in annualized cost savings achieved by december 31, 2022; $140 million realized to date strengthens balance sheet through accretive debt reduction of approximately us$160 million in 2022; strong cash position of approximately $393 million remains #1 canadian lp in high margin global medical cannabis revenues edmonton, ab , nov. 10, 2022 /prnewswire/ - aurora cannabis inc. (the "company" or "aurora") (nasdaq: ac) | (tsx: acb), the canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the fiscal first quarter ended september 30, 2022. as a reminder, fiscal 2023 will be comprised of three quarters, with the new fiscal year end being march 31, 2023.
ACB Ratings Summary
ACB Quant Ranking